Home - Products - MAPK/ERK Signaling - JNK - Caffeic Acid

Caffeic Acid

CAS No. 331-39-5

Caffeic Acid( —— )

Catalog No. M18430 CAS No. 331-39-5

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
50MG	30	Get Quote
100MG	42	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Caffeic Acid
Note

Research use only, not for human use.
Brief Description

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
Description

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

JNK
Recptor

Others
Research Area

Others-Field
Indication

——

Chemical Information

CAS Number

331-39-5
Formula Weight

180.16
Molecular Formula

C9H8O4
Purity

>98% (HPLC)
Solubility

DMSO : 106.7 mg/mL 592.25 mM
SMILES

c1cc(c(cc1/C=C/C(=O)O)O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Pradhananga S, Shim WS. Eur J Pharmacol. 2015 Sep 5;762:313-21.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BSJ-04-122

BSJ-04-122 is a covalent dual inhibitor of MKK4 and MKK7, demonstrating IC50 values of 4 nM and 181 nM, respectively. [BSJ-04-122] can be used for cancer research.
6-CFDA N-succinimidy...

The succinimidyl ester group is capable of spontaneously and irreversibly binding to free amines. Utilized in flow cytometry experiments for tracking cell division in both mammalian cells and bacteria.
JNK-IN-11

JNK-IN-11 (compound 1) is a potent inhibitor of JNK, with IC50 values of 2.2 μM, 21.4 μM, and 1.8 μM for JNK1, JNK2, and JNK3, respectively, showing potential for Alzheimer's and Parkinson's disease research.

Sign In Join Free